Get the Stockscreener App
1.45
4.61%
-0.07
After Hours:
1.45
Curis Inc stock is traded at $1.45, with a volume of 77,518.
It is down -4.61% in the last 24 hours and down -20.33% over the past month.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
See More
Previous Close:
$1.52
Open:
$1.59
24h Volume:
77,518
Relative Volume:
0.97
Market Cap:
$18.12M
Revenue:
$10.16M
Net Income/Loss:
$-47.57M
P/E Ratio:
-0.176
EPS:
-8.24
Net Cash Flow:
$-42.73M
1W Performance:
-12.65%
1M Performance:
-20.33%
6M Performance:
+23.93%
1Y Performance:
-72.64%
1-Day Range:
$1.43
$1.6196
1-Week Range:
$1.43
$1.70
52-Week Range:
$1.02
$5.5141
Curis Inc Stock (CRIS) Company Profile
Name
Curis Inc
Sector
Industry
Phone
617-503-6500
Address
128 SPRING STREET, LEXINGTON, MA
Compare CRIS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.45 | 19.00M | 10.16M | -47.57M | -42.73M | -8.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Apr-04-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Jul-29-20 | Initiated | Laidlaw | Buy |
| Jul-17-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Mar-02-16 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Nov-09-15 | Reiterated | ROTH Capital | Buy |
| Aug-11-15 | Initiated | FBR Capital | Outperform |
| Jan-22-15 | Reiterated | Oppenheimer | Outperform |
| Jan-21-15 | Reiterated | ROTH Capital | Buy |
| May-09-14 | Reiterated | Oppenheimer | Outperform |
| Oct-02-13 | Initiated | Robert W. Baird | Outperform |
| Sep-30-13 | Initiated | Chardan Capital Markets | Buy |
| Nov-14-12 | Initiated | Stifel Nicolaus | Hold |
| Jan-31-12 | Reiterated | Brean Murray | Buy |
| Jan-31-12 | Reiterated | Summer Street Research | Buy |
| Dec-09-11 | Initiated | Oppenheimer | Outperform |
| Oct-06-11 | Initiated | Summer Street Research | Buy |
| Sep-22-11 | Initiated | MLV Capital | Buy |
| Mar-21-11 | Reiterated | Brean Murray | Buy |
| Feb-26-10 | Reiterated | Roth Capital | Buy |
| Jan-07-10 | Initiated | Roth Capital | Buy |
View All
Curis Inc Stock (CRIS) Latest News
Can a trend reversal in Curis Inc. lead to recovery2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
Is Curis Inc. stock bottoming outQuarterly Profit Report & Daily Entry Point Trade Alerts - newser.com
Why Curis Inc. is moving todayJuly 2025 Rallies & Long Hold Capital Preservation Plans - newser.com
Will Curis Inc. stock recover after recent drop2025 Performance Recap & Entry Point Strategy Guides - newser.com
Curis Inc. stock daily chart insightsQuarterly Risk Review & Low Risk High Reward Ideas - newser.com
Has Curis Inc. formed a bullish divergenceInsider Selling & AI Enhanced Trading Alerts - newser.com
What is the Price Targets for Curis Inc (CRIS)? - fostersleader.com
Is Curis Inc. (CUS0) stock included in top ETFsWeekly Trade Report & Community Consensus Picks - newser.com
Curis Inc Stock Analysis and ForecastEarnings Forecast Updates & Get in Early on the Next Big Stock Surge - earlytimes.in
Is Curis Inc. building a consolidation baseQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Combining price and volume data for Curis Inc.Quarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Is Curis Inc. stock in correction or buying zoneQuarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com
What technical models suggest about Curis Inc.’s comeback2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Is a relief rally coming for Curis Inc. holdersMarket Growth Review & AI Driven Price Forecasts - newser.com
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Eastern Progress
Curis reports inducement grants under Nasdaq Listing Rule - MarketScreener
84,750 Shares: Curis Grants Inducement Options to Two New Employees with 4-yr Vesting - Stock Titan
Ranking Curis Inc. among high performing stocks via toolsJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com
Can you recover from losses in Curis Inc.Stop Loss & Verified Momentum Stock Watchlist - newser.com
How to read the order book for Curis Inc.Quarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Can Curis Inc. (CUS0) stock sustain breakout momentumTrade Analysis Report & Fast Momentum Entry Tips - newser.com
Can Curis Inc. (CUS0) stock attract ESG investments2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Advanced analytics toolkit walkthrough for Curis Inc.July 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
Analyzing Curis Inc. with risk reward ratio charts2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
Curis Inc Stock (CRIS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):